To include your compound in the COVID-19 Resource Center, submit it here.

Proteomic pathfinding

How Biognosys is mapping cell-wide drug-protein interactions

Biognosys is using a method developed by ETHZ researchers for the unbiased detection of molecular targets based on protein-metabolite interactions to study inter- and intra-patient variances in the proteome.

The protein services CRO will also offer the method to clients to help identify the proteins targeted by small molecule hits from phenotypic screens and to elucidate the molecules’ modes of action.

Previous methods for characterizing interactions between proteins and small

Read the full 680 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers